1w3 min read
Medical Article
Introduction Multiple sclerosis (MS) remains driven by immune activity in both the periphery and the CNS, with microglial-mediated inflammation contributing significantly to disability progression (1). Bruton’s tyrosine kinase (BTK) is central to signaling in B cells and innate immune cells, making it an emerging target for comprehensive MS immune

Clinical Case Study on Tolebrutinib in Relapsing Multiple Sclerosis
579 Reached1 Comments
Similar Content

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes

Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes

Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes

Headache with Clinically Non-functioning Pituitary Adenoma
818 Reached1 Comments4 Likes
